Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Symeres is a leading mid-sized transatlantic contract research and manufacturing organization specializing in small molecule drug discovery and development. With over three decades of experience, it provides integrated services from early hit finding to GMP manufacturing of clinical trial materials. The company has expanded its capabilities through acquisitions and strategic partnerships to offer medicinal chemistry, ADME-Tox profiling via the Admescope platform, process R&D, solid-state chemistry/formulation support, in vitro pharmacology including oncology assays via Oncolines, and CMC/drug product development. It serves global biotech and pharma companies but does not have its own proprietary pipeline or clinical results as it operates as a service provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symeres.